Clinical Trials | November 29, 2023
Roche expands hepatitis diagnostics portfolio
Almost 300 million people globally have chronic hepatitis B
Almost 300 million people globally have chronic hepatitis B
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
This surgery presented unique challenges, particularly due to the size of the gallbladder and the multitude of stones
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
The Oradox brand introduced a range of revolutionary products designed to elevate the standard of oral care
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Lupin Vilfuro-G is the only FDC that uniquely combines Vilanterol, Fluticasone Furoate and Glycopyrronium Bromide
Azelis will be the exclusive distributor for inulin, oligofructose, scFOS, texturized wheat proteins, faba beans, Beta-glucans, meatless solution
Jan Ausahdhi exhibited demonstration stall during 42nd India International Trade Fair to spread awareness
Subscribe To Our Newsletter & Stay Updated
